Choice of experimental model determines translational impact: The link between bisphenol A and cardiotoxicity.
Choice of experimental model determines translational impact: The link between bisphenol A and cardiotoxicity.
复制标题
实验模型的选择决定了转化影响:双酚 A 与心脏毒性之间的联系。
DOI:
10.1016/j.fct.2023.113667
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Posnack,NikkiGillum
中科院分区:
文献类型:
--
作者:
Cooper,BlakeL;Posnack,NikkiGillum
Bisphenol chemicals are nearly ubiquitous in our environment, and much attention has been given to their association with adverse health outcomes. In this issue of Food and Chemical Toxicology, we read with great interest the study by Ma et al., which reported that acute bisphenol A (BPA) exposure disturbs cardiac electrophysiology by delaying repolarization (Ma et al., 2023). Using isolated (female) canine ventricular cardiomyocytes, the authors report that BPA exhibits a non-monotonic dose response, wherein a low nanomolar concentration (1 nM BPA, akin to an environmental exposure) prolongs the cardiac action potential duration (APD) by approximately 10%. Further, the authors found negligible effects on the cardiac APD when either a lower picomolar concentration (1 pM) or higher micromolar concentration (1 μM) of BPA was applied to canine cardiomyocytes. It is not uncommon for endocrine-disrupting chemicals, including BPA, to display such unconventional dose-response relationships (Vandenberg, 2014). Although, in this new study, the dose-dependent effect of BPA on APD lengthening was more noticeable when measurements were normalized to each respective control–as the raw average APD50 and APD90 values were surprisingly comparable between cardiomyocytes treated with either 1 nM or 1 μM BPA (Figure 1C, F).The presented mechanistic studies by Ma et al. demonstrated that a low nanomolar concentration of BPA rapidly inhibits two currents: the outward IKr potassium current (-25%) and the inward ICaL calcium current (-9%). Follow-up computational modeling suggested that the inhibitory effect of BPA on IKr dominates at low nanomolar concentrations, which slows repolarization and prolongs the APD. Unfortunately, patch-clamp studies were limited to only the 1 nM BPA concentration, thus, it remains unclear how these inhibitory effects may change at lower or higher BPA doses. Although the half maximal inhibitory concentration (IC50) was not reported in this new study, previous studies reported an IC50> 100 μM BPA for IKr, an IC50= 7-31 μM BPA for ICaL, and a median inhibitory concentration of 27 nM BPA for ICaL (Hyun et al., 2021; Liang et al., 2014; Prudencio et al., 2021). Since these previous studies noted a monotonic dose response on current inhibition, it is plausible that the reported differences in BPA potency may be attributed to the use of different cell types (ie, transfected cell lines, human induced pluripotent stem cell-derived cardiomyocytes, rat or canine ventricular cardiomyocytes). When selecting an experimental model for toxicity studies, it is important to account for speciesspecific differences in cardiac electrophysiology and the human-relevant translational value (Odening et al., 2021)–which was clearly considered by the authors of this new study.